Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Ophthalmology
Cell & Gene Therapy
Drug Development
Small Molecule Research & Development
Fierce 50
Special Report
Awards Gala
Awards
Outsourcing Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Subscribe
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Ophthalmology
Cell & Gene Therapy
Drug Development
Small Molecule Research & Development
Fierce 50
Special Report
Awards Gala
Awards
Outsourcing Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
advisory committee
Biotech
AACR: Pazdur bemoans state of FDA, warns of political influence
Asked by Fierce if he'd consider returning to the FDA, Pazdur said he wouldn't serve again under the Trump administration "for obvious reasons."
Darren Incorvaia
Apr 18, 2026 4:00am
FDA panel votes against J&J shunt implant for heart failure
Dec 5, 2025 4:31pm
Fierce Pharma
ACIP narrowly votes against COVID vaccine prescriptions
Sep 19, 2025 5:22pm
FDA delays decision on Biohaven troriluzole filing, plans adcomm
May 15, 2025 6:02am
Lilly's donanemab sails through FDA meeting with 2 yes votes
Jun 10, 2024 5:11pm
Lykos' MDMA treatment rejected by FDA committee
Jun 5, 2024 10:20am